| |
Vascular
Research Division (DSM, PEO, GS, VMD), Department of Pathology, and Endocrine-Hypertension
Division (RMM), Department of Medicine, Brigham and Women's Hospital, and
Department of Pathology, Harvard Medical School, Boston, Massachusetts
|
| |
SUMMARY:
Leukocyte recruitment during inflammation is specified, in part, by the
spatial distribution and temporal regulation of endothelial adhesion molecules.
In this study we investigated the developmental onset of E-selectin and
intercellular adhesion molecule-1 (ICAM-1) basal expression and inducibility
by inflammatory mediators as indices of lineage-restricted endothelial
adhesion molecule expression. We studied both murine embryos and embryoid
bodies (EB), derived from differentiated embryonic stem cells, to examine
a broad range of endothelial ontogeny. Our results reveal that E-selectin
and ICAM-1 are differentially regulated during development and that three
stages define the ontogeny of the E-selectin-inducible response. The earliest
endothelial lineage cells in Day 4 and Day 5 EB did not express E-selectin
in the basal state or after stimulation. A second stage, observed between
embryonic Day 9.5 (E9.5) and E11.5 to E12.5 in cultured embryo cells and
transiently at Day 6 of EB differentiation, was characterized by basal
expression that was not stimulated by inflammatory mediators. A third
stage was characterized by both basal and inducible expression of E-selectin
and was observed beginning at E12.5 to E13.5 in cultured embryo cells
and at Day 7 in EB. In contrast ICAM-1 was stimulated at all of the embryonic
stages examined and before the onset of E-selectin inducibility in both
embryos and EB. E-selectin expression in embryos was also stimulated by
introducing endotoxin into the embryonic, but not the maternal, peritoneum.
This suggests that embryos are protected from inflammatory insults present
in the maternal circulation. The developmentally regulated acquisition
of E-selectin inducibility during embryogenesis likely involves changes
in signal transduction cascades, transcription factors, and/or chromatin
accessibility that specify inducible expression within the endothelial
lineage and further restrict inducibility to particular endothelial subpopulations.
|